Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

22 Résultats
authFullName_s : Olivier Casasnovas
Image document

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study.

Mira Tout , Olivier Casasnovas , Michel Meignan , Thierry Lamy , Franck Morschhauser et al.
Blood, 2017, 129 (19), pp.2616-2623. ⟨10.1182/blood-2016-10-744292⟩
Article dans une revue hal-01547802v1

Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia

Pierre Feugier , Thérèse Aurran , Beatrice Mahe , Remi Letestu , Florence C Nguyen-Khac et al.
Haematologica, 2018, 103 (7), pp.e304 - e306. ⟨10.3324/haematol.2017.183350⟩
Article dans une revue hal-01860422v1

The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition

Amina Bensalem , Guillaume Cartron , Ulrich Specks , Denis Mulleman , Emmanuel Gyan et al.
Clinical Pharmacokinetics, 2021, ⟨10.1007/s40262-021-01081-3⟩
Article dans une revue hal-03482193v1
Image document

Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group

Christophe Bonnet , Jehan Dupuis , Hervé Tilly , Thierry Lamy , Christophe Fruchart et al.
Cancers, 2022, 14 (7), pp.1761. ⟨10.3390/cancers14071761⟩
Article dans une revue hal-03660656v1

Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients

Anne-Ségolène Cottereau , Tarec C El-Galaly , Stéphanie Becker , Florence Broussais , Lars Jelstrup Peterson et al.
Journal of Nuclear Medicine, 2018, 59 (4), pp.589-595. ⟨10.2967/jnumed.117.193946⟩
Article dans une revue hal-01643956v1

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laetitia Vercellino , Roberta Di Blasi , Salim Kanoun , Benoit Tessoulin , Cedric Rossi et al.
Blood Advances, 2020, 4 (22), pp.5607-5615. ⟨10.1182/bloodadvances.2020003001⟩
Article dans une revue hal-03226567v1
Image document

Ibrutinib, Obinutuzumab And Venetoclax In Relapsed and Untreated Patients with Mantle-Cell Lymphoma, a phase I/II trial

Steven Le Gouill , Franck Morschhauser , David Chiron , Krimo Bouabdallah , Guillaume Cartron et al.
Blood, 2020, Online ahead of print. ⟨10.1182/blood.2020008727⟩
Article dans une revue inserm-03063717v1

Report of the 6th International Workshop on PET in lymphoma

Cristina Nanni , Anne Ségolène Cottereau , Egesta Lopci , Caroline Bodet-Milin , Monica Coronado et al.
Leukemia & lymphoma, 2017, 58 (10), pp.2298 - 2303. ⟨10.1080/10428194.2017.1298752⟩
Article dans une revue hal-01716432v1
Image document

Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia

Cécile Tomowiak , Stéphanie Poulain , Charles Herbaux , Aurore Perrot , Béatrice Mahé et al.
Blood Advances, 2021, 5 (9), pp.2438 - 2446. ⟨10.1182/bloodadvances.2020003895⟩
Article dans une revue hal-03251785v1

In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.

Louis Berthet , Alexandre Cochet , Salim Kanoun , Alina Berriolo-Riedinger , Olivier Humbert et al.
Journal of Nuclear Medicine, 2013, 54 (8), pp.1244-50. ⟨10.2967/jnumed.112.114710⟩
Article dans une revue hal-00927556v1
Image document

Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells

Jean Galtier , Laetitia Vercellino , Loic Chartier , Pierre Olivier , Claire Tabouret-Viaud et al.
Haematologica, 2020, 108 (1), pp.171-180. ⟨10.3324/haematol.2021.280550⟩
Article dans une revue inserm-03924745v1
Image document

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study

Amira Marouf , Anne Segolene Cottereau , Salim Kanoun , Paul Deschamps , Michel Meignan et al.
Haematologica, 2022, 107 (7), pp.1681-1686. ⟨10.3324/haematol.2021.279564⟩
Article dans une revue hal-03628340v1

[18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives

Salim Kanoun , Cédric Rossi , Olivier Casasnovas
Cancers, 2018, 10 (5), pp.145. ⟨10.3390/cancers10050145⟩
Article dans une revue hal-01922795v1

Prognostic value of baseline metabolic tumor volume in early stage Hodgkin's lymphoma in the standard arm of H10 trial

Anne Ségolène Cottereau , Annibale Versari , Annika Loft , Olivier Casasnovas , Monica Bellei et al.
Blood, 2018, 131 (13), pp.1456-1463. ⟨10.1182/blood-2017-07-795476⟩
Article dans une revue hal-01738084v1

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC / PVT1 predicts patient outcome in two independent cohorts

Hervé Ghesquières , Beth R. Larrabee , Olivier Casasnovas , Matthew Maurer , James D. Mckay et al.
British Journal of Haematology, 2018, 180 (2), pp.286 - 290. ⟨10.1111/bjh.14306⟩
Article dans une revue hal-01728832v1

Good clinical practice recommendations for the use of PET/CT in oncology

Pierre-Yves Salaün , Ronan Abgral , Olivier Malard , Solène Querellou-Lefranc , Gilles Quere et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 (1), pp.28-50. ⟨10.1007/s00259-019-04553-8⟩
Article dans une revue hal-03125498v1

BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres

Hervé Ghesquières , Cécile Dalban , Emmanuelle Nicolas‐virelizier , Fabrice Jardin , Fabien Le Bras et al.
British Journal of Haematology, 2021, 192 (3), pp.e94-e98. ⟨10.1111/bjh.17279⟩
Article dans une revue inserm-03349131v1
Image document

Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial

Benoit Tessoulin , David Chiron , Catherine Thieblemont , Lucie Oberic , Kamal Bouadballah et al.
Bone Marrow Transplantation, 2021, 56 (7), pp.1700-1709. ⟨10.1038/s41409-020-01198-2⟩
Article dans une revue hal-03203334v1
Image document

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Michael Wang , Simon Rule , Pier Luigi Zinzani , Andre Goy , Olivier Casasnovas et al.
The Lancet, 2018, 391 (10121), pp.659-667. ⟨10.1016/S0140-6736(17)33108-2⟩
Article dans une revue inserm-01980627v1

Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies

Julien Magne , Alizée Jenvrin , Adrien Chauchet , Olivier Casasnovas , Anne Donzel et al.
Experimental Hematology & Oncology, 2018, 7 (1), pp.5. ⟨10.1186/s40164-018-0097-6⟩
Article dans une revue hal-01731294v1

“Staging, restaging and treatment response assessment” in lymphomas: what we should know.

Salim Kanoun , Anne-Ségolène Cottereau , Alina Berriolo-Riedinger , Michel A. Meignan , Olivier Casasnovas et al.
Journal of Nuclear Medicine, 2018, 59 (4), pp.741-715. ⟨10.2967/jnumed.117.205351⟩
Article dans une revue hal-01689923v1

Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

Anne-Ségolène Cottereau , Irène Buvat , Salim Kanoun , Annibale Versari , Olivier Casasnovas et al.
2018, pp.1463 - 1464. ⟨10.1007/s00259-018-4005-4⟩
Autre publication scientifique hal-01824888v1